Fig. 2From: Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)The schedule of the protocol treatment of the present study. The schedule of GEM/nabPTX group is shown in a, and of GEM/nabPTX and levofloxacin combination group is shown in bBack to article page